Development of a nanobody-based competitive enzyme-linked immunosorbent assay for the sensitive detection of antibodies against porcine deltacoronavirus

文献类型： 外文期刊

第一作者： Yu, Ruiming

作者： Yu, Ruiming;Zhang, Liping;Bai, Yingjie;Zhou, Peng;Wang, Dongsheng;Wei, Liyang;Zhang, Zhongwang;Wang, Yonglu;Guo, Huichen;Pan, Li;Liu, Xinsheng;Yu, Ruiming;Zhang, Liping;Bai, Yingjie;Zhou, Peng;Wang, Dongsheng;Wei, Liyang;Zhang, Zhongwang;Wang, Yonglu;Guo, Huichen;Pan, Li;Liu, Xinsheng;Yu, Ruiming;Wang, Dongsheng;Yuan, Ligang;Yang, Jun;Yan, Chenghua

作者机构：

关键词： porcine deltacoronavirus; nanobody; cELISA

期刊名称：JOURNAL OF CLINICAL MICROBIOLOGY （ 影响因子：5.4； 五年影响因子：5.5 ）

ISSN： 0095-1137

年卷期： 2025 年 63 卷 3 期

页码：

收录情况： SCI

摘要： Porcine deltacoronavirus (PDCoV) is an emerging porcine enteric coronavirus causing significant economic losses to the pig farming industry globally. In this study, we expressed the S protein of a highly virulent PDCoV strain in the CHO eukaryotic expression system. After immunizing alpaca with the PDCoV S protein and employing the phage display library technique, a high-affinity and specific nanobody Nb3 against PDCoV S protein was successfully established by three rounds of biopanning and a phage enzyme-linked immunosorbent assay (ELISA). Furthermore, a competitive ELISA (cELISA) was developed based on Nb3 to rapidly and efficiently detect PDCoV antibody levels. The cELISA displayed no cross-reaction with positive sera of porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus (TGEV), porcine rotavirus (PoRV), pseudorabies virus (PRV), classical swine fever virus (CSFV), porcine reproductive and respiratory syndrome virus (PRRSV), or porcine circovirus 2 (PCV2), thereby showing good specificity. The cELISA successfully detected positive sera diluted 1:127 (percentage inhibition >= 50.02%), indicating high sensitivity. Both the intra- and inter-batch coefficients of variation were less than 10%, indicating good repeatability. The cELISA had a total coincidence rate of 98.33% with the indirect immunofluorescence assay and a significant positive correlation with the virus neutralization test (r = 0.861, P < 0.001), suggesting that the cELISA can be used to measure the neutralizing antibody titers in serum samples. In conclusion, our nanobody-based cELISA showed good performance indicators and can be used to monitor and evaluate antibody levels following clinical infection of PDCoV or vaccine immunization.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序